Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Reperfusion Injury × salicylhydroxamic acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Myocardial Reperfusion Injury 2 Cardiotoxicity 2 Vomiting 1 Uveal Melanoma 1 Thrombosis 1 Retinal Diseases 1 Reperfusion Injury 1 Pain, Postoperative 1 Nausea 1 Melanoma 1 Macular Degeneration 1 Lung Neoplasms 1 Kidney Neoplasms 1 Head and Neck Neoplasms 1 Choroid Diseases 1 Breast Neoplasms 1

Interventions

salicylhydroxamic acid 1 Morphine 1 Liver Transplantation 1 Ketorolac 1 Hepatectomy 1 Bupivacaine 1 Analgesia, Patient-Controlled 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02548377 2018-03-05

RIPC-HNC

Aarhus University Hospital Skejby

Phase NA Completed

Head and Neck Neoplasms, Thrombosis, Reperfusion Injury

Data powered by HemOnc (CC BY 4.0) Colophon ⚡